Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Less Radical, a podcast about Bernie Fisher, nominated for two Webby Awards

April 04, 2025
Vol.51 No.13
Clinical Roundup

Mass General study: Screenings for breast and colorectal cancer 4x higher than lung cancer

April 04, 2025
Vol.51 No.13
Clinical Roundup

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

April 04, 2025
Vol.51 No.13
Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted
FreeIn the Archives

Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted

March 28, 2025
Vol.51 No.12
In Brief

Tari King appointed chief surgical officer for cancer service line, co-director of Glenn Family Breast Center at Winship, chief of Division of Breast Surgery at Emory

March 14, 2025
Vol.51 No.10
In Brief

RWJBarnabas Health and Rutgers Cancer Institute open breast health center in East Brunswick

March 07, 2025
Vol.51 No.09
In Brief

Fred Hutch announces 10 recipients of the annual Harold M. Weintraub Graduate Student Award

March 07, 2025
Vol.51 No.09
In Brief

UVA Health expands breast cancer screening with mobile 3D mammography coach

February 28, 2025
Vol.51 No.08
Clinical Roundup

Breast cancer incidence, mortality cases projected to increase by 2050, study finds

February 28, 2025
Vol.51 No.08
Drugs & Targets

Tempus AI, Stemline Therapeutics collaborate to enhance ESR1 testing in breast cancer

February 28, 2025
Vol.51 No.08

Posts navigation

Previous1…678…32Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
  • NCI slated to get a $9 million raise as Trump’s budget proposes about 10% cut for NIH
  • FDA’s guidance on MRD in MM goes beyond the ODAC vote—and that’s where it matters most
    Draft guidance consolidates trial design updates for developers
  • Trump imposes up to 100% tariff on some brand name pharmaceutical companies
  • Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account